Anthracyclines in the treatment of solid tumors in children

Authors

  • Владимир Евгеньевич Белецкий Kharkiv Medica lAcademy of Postgraduate Education str. Korchagintsev, 58, Kharkov, Ukraine, 61176, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2015.41728

Keywords:

anthracyclines, doxorubicin, chemotherapy, cardiotoxicity, malignant tumors in children

Abstract

Aim: analysis of literary data on the use of anthracyclines in the treatment of solid tumors in children.

Methods: Review of the literature on the use of anthracyclines in the treatment of solid tumors in children. Discussion of the types of toxicity of doxorubicin and the search for ways to overcome the side effects of the drug.

Results: Most chemotherapy schemes that are used in the treatment of solid tumors in children include anthracyclines, among which the most popular is doxorubicin. Conducting chemotherapy, consisting of anthracyclines in children with various malignant tumors, can cause a number of toxic side effects, both during treatment and in long-term period.

Conclusions: The possibility of using doxorubicin limited by its toxic effects especially on the heart muscle. One of the challenges for further research is to find ways to reduce the cardiotoxicity of doxorubicin, while maintaining dose

Author Biography

Владимир Евгеньевич Белецкий, Kharkiv Medica lAcademy of Postgraduate Education str. Korchagintsev, 58, Kharkov, Ukraine, 61176

Assistant

Department of Oncology and Pediatric Oncology

References

Gelperina, S. E., Shvets, V. I. (2009). Drug delivery systems based on polymeric nanoparticles. Biotechnology, 3, 8–23.

Dudnichenko, A. S., Krasnopolskiy, Y. M., Shvets, V. I. (2001). Liposomal drugs in experimental and clinical. Kharkov, PA Caravel, 143.

Dedkov, A. G., Boychuk, S. І., Yugrinov, O. G. et. al. (2012). Іndivіdualіzatsіya hіmіoterapії from ailments for osteosarcoma fallow od angіografіchnih kriterіїv forecast lіkuvalnogo pathomorphosis. Klіnіchna onkologіya, 7, 22–26.

Anokhin, A. N., Chushkin, M. I., Kolganov, A. V. (2011). Anthracycline cardiomyopathy. Terapevt. arhiv, 10, 72–76.

Yerenkov, V. A. (1984). A clinical examination of a child. Kiev, Health, 230.

Krasnopolskiy, Y. M., Shvets, V. I. (2013). Technological principles of production of liposomal drugs and their use in the clinic. Nanotechnology and Health, 2, 6–7.

Aliyev, M. D., Polyakov, V. G., Mentkevicha, G. L., Beacon, S. A. (Eds.) (2012). Pediatric Oncology. Moscow: Publishing. Group RCRC. Practical medicine, 684.

Lanzkowsky. P. (Ed.) (2011). Manual of Pediatric Hematology and Oncology (Fifth Edition). Elsevier Inc., 1027.

Dudnіchenko, O. S., Klimnyuk, G. І., Bіletsky, V. E. (2013). Pediatric onkology. Kharkiv, "facts", 400.

byPizzo, F. A., Poplack, D. G. (Eds.) (2011). Principles and practice of Pediatric Oncology. Lippincott-Raven/Williams & Wilkins, 2011 Lippincott, 1531.

Published

2015-04-28

Issue

Section

Medical